Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

Intraoperative drug-eluting stent thrombosis in a patient undergoing robotic prostatectomy.

TitleIntraoperative drug-eluting stent thrombosis in a patient undergoing robotic prostatectomy.
Publication TypeJournal Article
Year of Publication2009
AuthorsSharma A, Berkeley A
JournalJ Clin Anesth
Volume21
Issue7
Pagination517-20
Date Published2009 Nov
ISSN1873-4529
KeywordsAged, Coronary Artery Disease, Drug-Eluting Stents, Electrocardiography, Fatal Outcome, Humans, Intraoperative Complications, Male, Platelet Aggregation Inhibitors, Prostatectomy, Prostatic Neoplasms, Robotics, Shock, Cardiogenic, Thrombosis, Ventricular Fibrillation
Abstract

Insertion of drug-eluting stents is one of the strategies for treating patients with coronary artery disease. These patients can be a perioperative challenge in management as they need to be maintained on antiplatelet therapy to prevent stent thrombosis, which puts them at an increased risk for surgical bleeding. Recently revised guidelines on elective surgery following insertion of a drug-eluting stent recommend dual antiplatelet therapy for a period of twelve months. The management of a patient who presented for surgery more than two years after the insertion of a drug-eluting stent, and who developed in-stent thrombosis intraoperatively, is presented.

DOI10.1016/j.jclinane.2008.11.013
Alternate JournalJ Clin Anesth
PubMed ID20006260